Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
-
First National Bank Alaska declares regular and special dividends for fourth quarter, both payable in December
-
Revolutionizing Mental Health: Dr. Anna Yusim Integrates Spirituality, Psychedelics, and Conscious Leadership at Global Summits
-
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at October 31, 2024
-
Trump Holds 7-point Lead Over Harris in Florida, New Stetson University Poll Finds
-
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Prime Drink Group Announces Closing of Triani Canada Acquisition
-
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
-
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
-
Legible Announces Appointment of Successor Auditor
-
Beasley Broadcast Group to Report 2024 Third Quarter Financial Results, Host Conference Call and Webcast on November 5
-
Vinesign Launches Powerful Public API, Empowering Businesses to Seamlessly Integrate E-Signature Solutions into Their Workflow
-
South Bow Recommends Shareholders Reject TRC Capital's Below-market "Mini-tender" Offer
-
South Bow Recommends Shareholders Reject TRC Capital's Below-market "Mini-tender" Offer
-
Nubian Grants Options
-
DFW Metro Gains Fifth New Rally House Store in 2024
-
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
-
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CNL Strategic Capital Launches Second Follow-On Offering of $1.1 Billion
-
Lumine Group Inc. Announces Results for the Three and Nine Months Ended September 30, 2024
-
Partners Value Investments L.P. Announces Changes to Internal Group Capital Structure
-
The New America High Income Fund, Inc. Declares Distribution
-
Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q
-
Prairie Operating Co. Announces Board Resignation
-
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
-
LeMaitre to Participate at Upcoming Investor Conferences in November
-
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
-
HOME FEDERAL BANCORP, INC. OF LOUISIANA ANNOUNCES APPROVAL OF STOCK REPURCHASE PROGRAM
-
LogicMark, Inc. Announces Adoption of Shareholder Rights Agreement
-
NACEPF and Mobile Beacon Urge the FCC Not to Adopt Additional Unnecessarily Restrictive Requirements for Wi-Fi Hotspots Funded Through E-Rate
-
Orca Energy Group Inc. Announces an Operational Update
-
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
-
Lilium N.V. Receives Notice of Delisting from Nasdaq
-
Intuitive Machines Announces Date for Third Quarter 2024 Financial Results Conference Call
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
ProStar Holdings Announces Closing of Non-Brokered Private Placement For Gross Proceeds of $1,775,000
-
Alberta Mule Deer Collaring Project to Launch in Winter 2024/25
-
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
-
Refined Energy Corp. Announces Marketing Program
-
Pennant Acquires Senior Living Communities in Wisconsin
-
Guggenheim Investments Announces November 2024 Closed-End Fund Distributions
-
Cornerstone Funds Announce Continuing Monthly Distributions and Reset Distribution Amounts for 2025
-
ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Nokia Corporation: Repurchase of own shares on 01.11.2024
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Canadian North Resources Inc. Announces Resignation of Rick Brown as a Director
-
NexQloud Wins Audience Choice Award at Blockchain Life 2024
-
Nuwellis Announces Preliminary Results for Third Quarter of 2024

